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Abstract
© 2017, Springer Science+Business Media New York.Selective agonist (Leu(31)Pro(34)NPY) and
blocker (BIBP-3226) of  NPY1 receptors were used to determine the type of  NPY receptors
involved in myocardial contraction. Experiments with isometric contraction of myocardial strips
from mature rats showed that the agonist produced the most potent effect in a concentration of
10—7 M. In this concentration, Leu(31)Pro(34)NPY showed the greatest positive inotropic effect
on the contraction of the atria and ventricles. In contrast, selective blocker BIBP-3226 reduced
the  force  of  myocardial  contractions.  Pretreatment  of  myocardial  strips  with  this  blocker
abolished the positive inotropic effect of Leu(31)Pro(34)NPY, which attested to important role of
NPY1 receptors in myocardial contraction.
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